Table 1 Characteristics of patients consulting for chest pain before and during COVID-19 lockdown1

Age (years (SD))⁴

65 (14)

66 (14)

0.140

Sex (male, n(%))

4,014 (43)

291 (43)

0.700

Medical history, n(%)

 History of CVD⁵

2,643 (29)

246 (36)

< 0.001

  Coronary arterial disease

1,628 (18)

150 (22)

0.004

  Cerebrovascular disease

484 (5.2)

50 (7.4)

0.019

  Peripheral arterial disease

203 (2.2)

24 (3.5)

0.025

 Diabetes mellitus

850 (9.2)

85 (13)

0.005

 Hypertension

1,944 (21)

175 (26)

0.004

 Hypercholesterolemia

527 (5.7)

41 (6.0)

0.700

 COPD⁶

336 (3.6)

19 (2.8)

0.300

 Depression

446 (4.8)

37 (5.4)

0.500

Medication, n(%)

 Antiplatelet therapy

2,166 (23)

218 (32)

< 0.001

 Oral anticoagulation⁷

1,006 (11)

95 (14)

0.014

 Antihypertensives

4,417 (48)

383 (56)

< 0.001

 Beta-blockers

2,476 (27)

221 (33)

0.001

 Statin

3,021 (33)

263 (39)

0.001

 Insulin therapy

423 (4.6)

39 (5.7)

0.2

Type of contact, n(%)

 Live consultation

6,633 (72)

331 (49)

< 0.001

 Telephone consultation

2,067 (22)

325 (48)

< 0.001

 Home visit

523 (5.7)

22 (3.2)

0.007

 E-consultation

5 (< 0.1)

2 (0.3)

0.078

Referred (yes), n(%)

1,787 (19)

67 (9.9)

< 0.001

Diagnosis of acute coronary syndrome⁸, n(%)

910 (9.9)

80 (12)

0.11